Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve capacity in dementia diagnostics to facilitate access to new dementia treatments.

The Government is committed to transforming diagnostic services and will support the National Health Service to increase diagnostic capacity to meet the demand for diagnostic services through investment in new capacity, including magnetic resonance imaging and computed tomography scanners.

Our Elective Reform Plan, published in January 2025, builds on the investments already made with an ambitious vision for the future of diagnostic testing. This will include more straight-to-test pathways, increasing and expanding community diagnostic centres (CDCs), and better use of technology. With 170 CDCs due to be up and running by the end of March 2025, CDCs can take on more of the growing diagnostic demand within elective care. We will also deliver additional CDC capacity in 2025/26 by expanding several existing CDCs and building up to five new ones.

To prepare for the new generation of dementia treatments in development, NHS England is working closely with regulators to ensure that arrangements are in place to support the adoption of any new licensed and treatments recommended by the National Institute for Health and Care Excellence as soon as possible.

Alongside Alzheimer’s Research UK, Alzheimer’s Society, Gates Ventures and the People’s Postcode Lottery, the National Institute for Health Research is funding the Blood Biomarker Challenge which seeks to produce the clinical and economic data that could make the case for the use of a blood test in the NHS to support diagnosis of dementia.